Core Insights - Southbound funds increased their holdings in Alibaba Health (00241.HK) by 8.332 million shares on March 30 [1] - Over the past 5 trading days, there were 3 days of net increases in holdings, totaling 4.2241 million shares [1] - In the last 20 trading days, there were 13 days of net increases, amounting to 38.2002 million shares [1] - Currently, southbound funds hold 2.019 billion shares of Alibaba Health, representing 12.47% of the company's total issued ordinary shares [1] Company Overview - Alibaba Health Information Technology Co., Ltd. provides industrial internet solutions for the medical and pharmaceutical industry [1] - The company is the flagship platform of Alibaba Group in the health sector, primarily engaged in the sales of pharmaceutical health products [1] - It operates a pharmaceutical e-commerce platform and consumer healthcare service platform, utilizing cloud computing and big data for traceability and digital healthcare [1]

Core Viewpoint - Southbound funds have increased their holdings in Alibaba Health (00241.HK) significantly, indicating growing investor interest in the company [1] Group 1: Investment Activity - On March 27, southbound funds increased their holdings by 4.576 million shares of Alibaba Health [1] - Over the past five trading days, there have been three days of net increases in holdings, totaling 999,100 shares [1] - In the last 20 trading days, there were 12 days of net increases, amounting to 25.2663 million shares [1] - Currently, southbound funds hold 2.011 billion shares of Alibaba Health, representing 12.42% of the company's total issued ordinary shares [1] Group 2: Company Overview - Alibaba Health Information Technology Co., Ltd. provides industrial internet solutions for the healthcare and pharmaceutical industry [1] - The company is the flagship platform of Alibaba Group in the health sector, focusing on the development of pharmaceutical health product sales [1] - It operates an e-commerce platform for pharmaceuticals and consumer healthcare services, utilizing cloud computing and big data for traceability and digital healthcare [1]

Group 1 - Southbound funds reduced their holdings in Alibaba Health (00241.HK) by 6.39 million shares on March 25 [1] - Over the past 5 trading days, southbound funds increased their holdings on 3 days, with a total net increase of 1.62 million shares [1] - In the last 20 trading days, there were 11 days of net increases by southbound funds, totaling 20.04 million shares [1] - Currently, southbound funds hold 2.005 billion shares of Alibaba Health, accounting for 12.39% of the company's total issued ordinary shares [1] Group 2 - Alibaba Health Information Technology Co., Ltd. provides industrial internet solutions for the medical and pharmaceutical industry [2] - The company is the flagship platform of Alibaba Group in the health sector, primarily engaged in the sales of pharmaceutical health products [2] - Alibaba Health operates an e-commerce platform for pharmaceuticals and a consumer healthcare service platform, utilizing cloud computing and big data for traceability and digital healthcare [2]

Core Insights - Southbound funds increased their holdings in Alibaba Health (00241.HK) by 5.106 million shares on March 23 [1] - Over the past 5 trading days, there has been a cumulative net increase of 22.4814 million shares from southbound funds [1] - In the last 20 trading days, there were 13 days of net increases totaling 41.6112 million shares [1] - As of now, southbound funds hold 2.015 billion shares of Alibaba Health, representing 12.45% of the company's total issued ordinary shares [1] Company Overview - Alibaba Health Information Technology Co., Ltd. is an investment holding company providing industrial internet solutions for the healthcare and pharmaceutical industry [1] - The company primarily engages in the sales of pharmaceutical health products and operates e-commerce platforms for pharmaceuticals and consumer healthcare services [1] - It leverages technologies such as cloud computing and big data to develop traceability, digital healthcare, and internet medical services [1]

Group 1 - Southbound funds increased their holdings in Alibaba Health (00241.HK) by 2.146 million shares on March 20 [1] - Over the past 5 trading days, there were 4 days of net increases in holdings by southbound funds, totaling 15.4508 million shares [1] - In the last 20 trading days, there were 12 days of net increases, amounting to 34.0052 million shares [1] Group 2 - As of now, southbound funds hold 2.01 billion shares of Alibaba Health, representing 12.41% of the company's total issued ordinary shares [1] - Alibaba Health Information Technology Co., Ltd. provides industrial internet solutions for the medical and pharmaceutical industry [1] - The company is primarily engaged in the sales of pharmaceutical health products and operates e-commerce platforms for pharmaceuticals and consumer healthcare services [1]

Group 1 - The core point of the article highlights that southbound funds have increased their holdings in Alibaba Health (00241.HK) by 8.03 million shares on March 18, with a total net increase of 7.27 million shares over the last five trading days [1] - Over the past 20 trading days, southbound funds have increased their holdings on 12 occasions, resulting in a cumulative net increase of 38.56 million shares [1] - As of now, southbound funds hold 2.004 billion shares of Alibaba Health, accounting for 12.37% of the company's total issued ordinary shares [1] Group 2 - Alibaba Health Information Technology Co., Ltd. is a holding company that provides industrial internet solutions for the healthcare and pharmaceutical industry, serving as Alibaba Group's flagship platform in the health sector [1] - The company primarily engages in the sales of pharmaceutical health products, operates a pharmaceutical e-commerce platform, and offers consumer healthcare services, utilizing technologies such as cloud computing and big data to develop traceability, digital healthcare, and internet medical services [1]

Group 1 - The core point of the article highlights the recent trading activity of southbound funds in Alibaba Health, indicating a net increase in holdings despite some days of reduction [1] - On March 17, southbound funds increased their holdings by 3.463 million shares of Alibaba Health (00241.HK) [1] - Over the past 5 trading days, there were 3 days of net reduction totaling 2.2514 million shares [1] Group 2 - In the last 20 trading days, there were 12 days of net increases in holdings, amounting to a total of 38.9947 million shares [1] - As of now, southbound funds hold 1.996 billion shares of Alibaba Health, which represents 12.33% of the company's total issued ordinary shares [1] - Alibaba Health Information Technology Co., Ltd. is a holding company providing industrial internet solutions for the medical and pharmaceutical industry, primarily engaged in the sales of health products and operating e-commerce platforms for pharmaceuticals and consumer healthcare services [1]

Group 1 - The core point of the article highlights the recent trading activity of southbound funds in Alibaba Health, indicating a reduction of 192.46 million shares on March 16, while also noting a net increase of 282.96 million shares over the last five trading days [1] - Over the past 20 trading days, Alibaba Health has seen a net increase of 47.19 million shares from southbound funds, with 12 days of net buying [1] - As of now, southbound funds hold 1.992 billion shares of Alibaba Health, representing 12.31% of the company's total issued ordinary shares [1] Group 2 - Alibaba Health Information Technology Co., Ltd. is a holding company providing industrial internet solutions for the medical and pharmaceutical industry, serving as Alibaba Group's flagship platform in the health sector [1] - The company primarily engages in the sales of pharmaceutical health products, operates an e-commerce platform for pharmaceuticals, and offers consumer healthcare services, leveraging technologies such as cloud computing and big data for traceability and digital healthcare [1]

Core Viewpoint - Southbound funds have significantly increased their holdings in Alibaba Health, indicating growing investor confidence in the company and its market position [1] Group 1: Investment Activity - On March 12, southbound funds increased their holdings by 1.998 million shares of Alibaba Health (00241.HK) [1] - Over the past five trading days, there have been three days of net increases, totaling 9.559 million shares [1] - In the last 20 trading days, there were 14 days of net increases, amounting to 60.5304 million shares [1] - Currently, southbound funds hold 1.998 billion shares of Alibaba Health, representing 12.35% of the company's total issued ordinary shares [1] Group 2: Company Overview - Alibaba Health Information Technology Co., Ltd. is an investment holding company providing industrial internet solutions for the healthcare and pharmaceutical industry [1] - The company primarily engages in the sales of pharmaceutical health products and operates e-commerce platforms for pharmaceuticals and consumer healthcare services [1] - It leverages technologies such as cloud computing and big data to develop traceability, digital healthcare, and internet medical services [1]

Core Viewpoint - Southbound funds reduced their holdings in Alibaba Health (00241.HK) by 1.4938 million shares on March 11, indicating a fluctuation in investor sentiment towards the company [1] Group 1: Southbound Fund Activity - Over the past five trading days, southbound funds increased their holdings on two occasions, with a total net increase of 7.467 million shares [1] - In the last twenty trading days, there were thirteen days of net increases, totaling 32.6604 million shares [1] - Currently, southbound funds hold 1.996 billion shares of Alibaba Health, representing 12.34% of the company's total issued ordinary shares [1] Group 2: Company Overview - Alibaba Health Information Technology Co., Ltd. is an investment holding company providing industrial internet solutions for the healthcare and pharmaceutical industry [1] - The company primarily engages in the sales of pharmaceutical health products and operates e-commerce platforms for pharmaceuticals and consumer healthcare services [1] - It leverages technologies such as cloud computing and big data to develop traceability, digital healthcare, and internet medical services [1]